Cargando…
Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab)
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811298/ https://www.ncbi.nlm.nih.gov/pubmed/33488880 http://dx.doi.org/10.5114/aoms.2020.101510 |
| _version_ | 1783637468104359936 |
|---|---|
| author | Ouyang, Han Wen, Jian Song, Kai |
| author_facet | Ouyang, Han Wen, Jian Song, Kai |
| author_sort | Ouyang, Han |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7811298 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Termedia Publishing House |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78112982021-01-22 Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab) Ouyang, Han Wen, Jian Song, Kai Arch Med Sci Letter to the Editor Termedia Publishing House 2020-12-04 /pmc/articles/PMC7811298/ /pubmed/33488880 http://dx.doi.org/10.5114/aoms.2020.101510 Text en Copyright: © 2020 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
| spellingShingle | Letter to the Editor Ouyang, Han Wen, Jian Song, Kai Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab) |
| title | Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab) |
| title_full | Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab) |
| title_fullStr | Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab) |
| title_full_unstemmed | Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab) |
| title_short | Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab) |
| title_sort | decreased interleukin-35 levels and cd4(+)ebi3(+) t cells in patients with type 1 diabetes and the effects of the antibody against cd20 (rituximab) |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811298/ https://www.ncbi.nlm.nih.gov/pubmed/33488880 http://dx.doi.org/10.5114/aoms.2020.101510 |
| work_keys_str_mv | AT ouyanghan decreasedinterleukin35levelsandcd4ebi3tcellsinpatientswithtype1diabetesandtheeffectsoftheantibodyagainstcd20rituximab AT wenjian decreasedinterleukin35levelsandcd4ebi3tcellsinpatientswithtype1diabetesandtheeffectsoftheantibodyagainstcd20rituximab AT songkai decreasedinterleukin35levelsandcd4ebi3tcellsinpatientswithtype1diabetesandtheeffectsoftheantibodyagainstcd20rituximab |